ESTI 2019 / P-0055
Significance of baseline CT assessment for predicting the pulmonary fibrosis during the course of chemotherapy-induced pneumonitis
Keywords:
Drugs / Reactions, Cancer, Complications, Chemotherapy, CT, Thorax, Lung
Authors:
J.-Y. Han, J. W. Baek, K.-N. Lee, S. J. Choi; Busan/KR
DOI:
10.26044/esti2019/P-0055
References
- Dimopoulou,
I.,
et al.,
Pulmonary toxicity from novel antineoplastic agents.
Ann Oncol,
2006.
17(3): p.
372-9.
- Vahid,
B.
and P.E.
Marik,
Pulmonary complications of novel antineoplastic agents for solid tumors.
Chest,
2008.
133(2): p.
528-38
- Sakurada,
T.,
et al.,
Characteristics of and risk factors for interstitial lung disease induced by chemotherapy for lung cancer.
Ann Pharmacother,
2015.
49(4): p.
398-404.
- Akira,
M.,
H.
Ishikawa,
and S.
Yamamoto,
Drug-induced pneumonitis: thin-section CT findings in 60 patients.
Radiology,
2002.
224(3): p.
852-60.
- Lee,
H.N.,
et al.,
Thin-Section CT Characteristics and Longitudinal CT Follow-up of Chemotherapy Induced Interstitial Pneumonitis: A Retrospective Cohort Study.
Medicine (Baltimore),
2016.
95(2): p.
e2460.
- Naranjo,
C.A.,
et al.,
A method for estimating the probability of adverse drug reactions.
Clin Pharmacol Ther,
1981.
30(2): p.
239-45.
- Silva,
C.I.
and N.L.
Muller,
Drug-induced lung diseases: most common reaction patterns and corresponding high-resolution CT manifestations.
Semin Ultrasound CT MR,
2006.
27(2): p.
111-6.
- Cleverley,
J.R.,
et al.,
Drug-induced lung disease: high-resolution CT and histological findings.
Clin Radiol,
2002.
57(4): p.
292-9.
-